I heard of a poster on tool comparison in one of the threads.. other useful stuff..
Unconfigured Ad
Collapse
X
-
Heh! Awesome! Well, I'll be there presenting a poster on some of my work - the part that doesn't relate to FindPeaks. I'll also be trying to blog the talks I attend. If anyone from SeqAnswers also wants to meet up, that could be cool.The more you know, the more you know you don't know. —Aristotle
Comment
-
That's true. Maybe ECO should just put up a SEQAnswers poster somewhere for all of us to congregate around.
Oh well - how about this, if people are interested, they should let me know: either find me at my poster, send me an email or leave a message here. If a couple of people come forward, I'll try to arrange something.The more you know, the more you know you don't know. —Aristotle
Comment
-
apfejes! your blog posts are great!
Hope you don't mind me advertising for you. :P
For those who didn't go to AGBT, visit the blog:
Comment
-
Thanks (=
I'm glad they're useful. It makes my sore wrists feel better, knowing that someone is getting some out of them. I'll get around to making a page with an index of all the talks - but probably not 'till the weekend.The more you know, the more you know you don't know. —Aristotle
Comment
-
thanks to you, even though I didn't attend, I feel that I was able to get a good feel of the conference! I look forward to your future organization and updates.
Comment
-
Ok, after some playing around, I figured out how to make a single collection of my AGBT 2009 notes. Here you go:
The more you know, the more you know you don't know. —Aristotle
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
Yesterday, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 02:55 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
Comment